The previous executive profiles we did, namely on Joern Aldag and Philippe Dro, are hard acts to follow, but Bernard Gilly was more than up to it. Bernard has a broad set of achievements for a broad set of lessons and takeaways. Here are the major ones.
You might have seen Bernard Gilly’s name in the headlines recently for the successful IPO of Gensight, one of the leading gene therapy companies in ophthalmology. He founded the company, invested in it through his own fund, and is still leading it as CEO. Before that, he founded and led Pixium Vision, which developed the most advanced artificial retina sold in Europe today; at the same time, he started iBionext, the fund he used to support Pixium Vision, and raised over €250M raised in 4 years.
